A novel transcatheter-implanted system that shunts blood flow from the left to right atrium through the coronary sinus has ...

Slower gait speed, but not handgrip strength or muscle mass, is associated with an increased risk for cardiovascular outcomes ...

By Dr. Sanchari Sinha Dutta, Ph.D. A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets ...

A multi-institutional research team led by Osaka University found that tricaprin, a natural supplement, improved long-term ...

A national clinical trial is underway to compare a novel mechanical heart pump to the only device currently used to treat end-stage heart failure. The INNOVATE study, led by University of Michigan, wi ...

The ancient Greek philosopher and polymath Aristotle once concluded that the human heart is tri-chambered and that it was the ...

Bayer has filed its mineralocorticoid receptor antagonist (MRA) finerenone as a treatment for a common form of heart failure ...

The FDA today issued a notice informing customers of updated instructions for the Johnson & Johnson Abiomed Impella RP heart pump.

Bayer seeks European marketing approval for use of finerenone in adult patients with HF with a left ventricular ejection fraction (LVEF) of =40%: Berlin Tuesday, February 4, 2025, ...

Berlin: Bayer has announced the submission of a marketing authorization application to the European Medicines Agency (EMA), ...